July 24 Product: BioMarins Brineura Indication: Batten disease BioMarin secured an expanded approval Wednesday for Brineura, its treatment for the genetic condition called neuronal ceroid lipofuscinosis type 2 (CLN2) disease
Yes, it promotes energy production in the brain and body, helping reduce feelings of mental and physical fatigue
Lab results show that s-acetyl glutathione raised intracellular glutathione while having a positive impact on many oxidative stress biomarkers.
Relax and Replenish An IV typically takes around one hour, though timing varies depending on hydration and individual factors
Protein & EAAs Increase fullness and help preserve lean muscle, which can support healthy weight management
Early clinical studies can then adopt metabolically defined enrichment strategies and a small set of pre-specified pharmacodynamic endpoints linking target engagement to intratumoral lactate and tissue lactylation, while evaluating mechanism-based combinations, including immunotherapy, within adaptive designs [39]